Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Currently, there are more companies enter into POC Diagnostics industry in the world, especially in USA. The main market players are, Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, etc.
Alere is the largest supplier of POC Diagnostics, with the revenue market share about 18% in 2015, and the top 6 supplier of POC Diagnostics, with the revenue market share about 68% in 2015. That is to say, the industry of POC Diagnostics is relative concentration.
There are nine kinds of POC Diagnostics, which are Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing and Cholesterol Testing. Blood Glucose Testing is wildly used in the POC Diagnostics, with a revenue market share nearly 46% in 2015. The fastest-growing segment, Cardiac Markers Testing, is projected to increase at a CAGR of 13%.
POC Diagnostics is used in Clinics, Hospitals, Laboratory and Others. Report data showed that 42.3% of the POC Diagnostics market demand in Clinics application, 34.4% in Hospitals application, and 4.9% in Laboratory application in 2015.
Development Tendency
Briefly speaking, in the next few years, POC Diagnostics industry will still be a highly energetic industry. Revenue of POC Diagnostics have brought a lot of opportunities there will more companies enter into this industry, especially in developing countries.
The global POC Diagnostics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the POC Diagnostics market based on company, product type, end user and key regions.
This report studies the global market size of POC Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of POC Diagnostics in these regions.
This research report categorizes the global POC Diagnostics market by top players/brands, region, type and end user. This report also studies the global POC Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Market size by Product
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Market size by End User
Clinics
Hospitals
Laboratory
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global POC Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of POC Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global POC Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of POC Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of POC Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of POC Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on POC Diagnostics . Industry analysis & Market Report on POC Diagnostics is a syndicated market report, published as Global POC Diagnostics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of POC Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.